Multiple mites in eyelashes with crusties

Are YourEyelids HostingA Mite Party?

If you're experiencing eyelid itching or crusties (collarettes), you're not alone.^1-3

XDEMVY^® can help break up mite parties by targeting and killing the Demodex mites that cause Demodex blepharitis (DB).^4,5 If you are unsure about whether you have DB, answer a few questions to uncover its impact on you.

Take Quiz Now See how XDEMVY works

Are YourEyelids HostingA Mite Party?

If you're experiencing eyelid itching or crusties (collarettes), you're not alone.^1-3

Take Quiz Now See how XDEMVY works

See XDEMVY in Action

With a simple swipe, view the impact of XDEMVY treatment on eyelids with DB.

View BEFORE and AFTER photos from actual patients by selecting below.

Real patient with DB used XDEMVY twice daily, in each eye, for 6 weeks. Results may vary.

BEFORE

AFTER

Party's Over With XDEMVY

IT’S NOT YOU—IT’S DEMODEX MITES

If mites are having a party on your eyelids, it’s time to eliminate the root of the problem.⁴ Watch this video now.

Dr Canseco

TREATING DB WITH XDEMVY

Dr Canseco discusses the process of diagnosing DB and the ability to treat it with XDEMVY.

QUESTIONS ABOUT XDEMVY?

Connect with our XDEMVY Concierge Chatbot for
answers about Demodex blepharitis and XDEMVY.

CHAT NOW

DB doctors near you

Locate DB-knowledgeable eye doctors in your area.

Find an eye doctor

demodex mite saying oh no with text that reads party’s over

References

References: 1. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. 2. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 3. Sędzikowska A, Osęka M, Grytner-Zięcina B. Ocular symptoms reported by patients infested with Demodex mites. Acta Parasitol. 2016;61(4):808-814. 4. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 5. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

By prescription only.

Are YourEyelids HostingA Mite Party?

Are YourEyelids HostingA Mite Party?

See XDEMVY in Action

IT’S NOT YOU—IT’S DEMODEX MITES

TREATING DB WITH XDEMVY

QUESTIONS ABOUT XDEMVY?

DB doctors near you

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

HAVE EYELID ISSUES?

Still have questions?

HAVE EYELID ISSUES?

You are leaving the XDEMVY^® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY^® patient website and going to the healthcare professional website.

You are leaving the XDEMVY^® patient website.